The Food and Drug Administration gave Pfizer, maker of the canine arthritis drug Rimadyl, a slap on the wrist over marketing materials produced by the company.
In the release, dated Nov. 24, 2008, the FDA found several instances where Pfizer's marketing materials for Rimadyl "make unsubstantiated safety claims and minimize the risk associated with Rimadyl®." The FDA went on to request that Pfizer withdraw the misleading materials, as well as any other marketing materials making similar claims from the marketplace.
Fascinating. A major pharmaceutical company making less-than-truthful claims about the efficacy of one of their drugs. Who would have thought?
To read the full release, click here for the PDF.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment